31703578|t|Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.
31703578|a|BACKGROUND: Preeclampsia (PE), as a multisystem disorder, is associated with maternal hypertension and proteinuria. Apoptosis seems to be involved in the pathophysiology of PE, although its precise pathogenic mechanisms are not well established. In this study, we aimed to identify the association between maternal TP53-rs1042522, P21-rs1801270, and P21-rs1059234 polymorphisms and PE. In addition, we examined the effects of promoter methylation and TP53 and P21 polymorphisms on placental mRNA expression in PE women. METHODS: The blood of 226 PE women and 228 normotensive pregnant women was examined in this study. In addition, the placentas were genotyped in 109 PE and 112 control women. The methylation status was assessed by a methylation-specific PCR assay, while mRNA expression was examined via Quantitative Real Time PCR. RESULTS: The maternal and placental P21-rs1801270 CA genotype had a significant association with the reduced risk of PE. In the dominant, recessive, and allelic models, maternal/placental P21-rs1059234 polymorphism had no statistically significant association with the risk of PE. On the other hand, the reduced risk of PE was associated with maternal, but not placental TP53-rs1042522 polymorphism in the dominant and recessive models. The maternal and placental P21-rs1801270 polymorphism was associated with PE risk. The maternal P21 Trs1059234Crs1801270 haplotype was associated with 3.4-fold increase in PE risk, However the maternal P21 Trs1059234Ars 1801270 haplotype and placental Crs1059234CA rs1801270 haplotype led to 0.5 and 0.4-fold decrease in PE risk, respectively. PE women showed 5.6 times higher levels of placental mRNA expression of TP53 gene, although it was not associated with rs1042522 polymorphism. The relative placental mRNA expression of P21 gene was 0.2 in PE women. It was also 2.4 times higher in individuals with rs1801270CA genotype than those with AA genotype. The hyper-methylation of P21 and TP53 genes in the promoter region was associated with a 3.4-fold and 3-fold increase in PE risk, respectively. However, no association was found between P21 and TP53 mRNA expression and promoter methylation. CONCLUSION: In conclusion, P21-rs1801270 and TP53-rs1042522 polymorphisms were involved in reduced risk of PE. P21-rs1801270 was associated with decreased P21 mRNA expression. The hyper-methylation of P21 and TP53 genes in the promoter region was associated with a higher PE risk.
31703578	103	106	P53	Gene	7157
31703578	111	114	P21	Gene	644914
31703578	124	136	preeclamptic	Disease	MESH:C538543
31703578	163	168	women	Species	9606
31703578	182	194	Preeclampsia	Disease	MESH:D011225
31703578	196	198	PE	Disease	MESH:D011225
31703578	256	268	hypertension	Disease	MESH:D006973
31703578	273	284	proteinuria	Disease	MESH:D011507
31703578	343	345	PE	Disease	MESH:D011225
31703578	485	489	TP53	Gene	7157
31703578	490	499	rs1042522	SNP	tmVar:rs1042522;VariantGroup:2;CorrespondingGene:7157;RS#:1042522;CorrespondingSpecies:9606
31703578	501	504	P21	Gene	644914
31703578	505	514	rs1801270	SNP	tmVar:rs1801270;VariantGroup:0;CorrespondingGene:1026;RS#:1801270;CorrespondingSpecies:9606
31703578	520	523	P21	Gene	644914
31703578	524	533	rs1059234	SNP	tmVar:rs1059234;VariantGroup:1;CorrespondingGene:1026;RS#:1059234;CorrespondingSpecies:9606
31703578	552	554	PE	Disease	MESH:D011225
31703578	621	625	TP53	Gene	7157
31703578	630	633	P21	Gene	644914
31703578	680	682	PE	Disease	MESH:D011225
31703578	683	688	women	Species	9606
31703578	716	718	PE	Disease	MESH:D011225
31703578	719	724	women	Species	9606
31703578	755	760	women	Species	9606
31703578	838	840	PE	Disease	MESH:D011225
31703578	857	862	women	Species	9606
31703578	1040	1043	P21	Gene	644914
31703578	1044	1053	rs1801270	SNP	tmVar:rs1801270;VariantGroup:0;CorrespondingGene:1026;RS#:1801270;CorrespondingSpecies:9606
31703578	1121	1123	PE	Disease	MESH:D011225
31703578	1192	1195	P21	Gene	644914
31703578	1196	1205	rs1059234	SNP	tmVar:rs1059234;VariantGroup:1;CorrespondingGene:1026;RS#:1059234;CorrespondingSpecies:9606
31703578	1281	1283	PE	Disease	MESH:D011225
31703578	1324	1326	PE	Disease	MESH:D011225
31703578	1375	1379	TP53	Gene	7157
31703578	1380	1389	rs1042522	SNP	tmVar:rs1042522;VariantGroup:2;CorrespondingGene:7157;RS#:1042522;CorrespondingSpecies:9606
31703578	1468	1471	P21	Gene	644914
31703578	1472	1481	rs1801270	SNP	tmVar:rs1801270;VariantGroup:0;CorrespondingGene:1026;RS#:1801270;CorrespondingSpecies:9606
31703578	1515	1517	PE	Disease	MESH:D011225
31703578	1537	1540	P21	Gene	644914
31703578	1613	1615	PE	Disease	MESH:D011225
31703578	1643	1646	P21	Gene	644914
31703578	1706	1715	rs1801270	SNP	tmVar:rs1801270;VariantGroup:0;CorrespondingGene:1026;RS#:1801270;CorrespondingSpecies:9606
31703578	1762	1764	PE	Disease	MESH:D011225
31703578	1785	1787	PE	Disease	MESH:D011225
31703578	1788	1793	women	Species	9606
31703578	1857	1861	TP53	Gene	7157
31703578	1904	1913	rs1042522	SNP	tmVar:rs1042522;VariantGroup:2;CorrespondingGene:7157;RS#:1042522;CorrespondingSpecies:9606
31703578	1970	1973	P21	Gene	644914
31703578	1990	1992	PE	Disease	MESH:D011225
31703578	1993	1998	women	Species	9606
31703578	2124	2127	P21	Gene	644914
31703578	2132	2136	TP53	Gene	7157
31703578	2220	2222	PE	Disease	MESH:D011225
31703578	2285	2288	P21	Gene	644914
31703578	2293	2297	TP53	Gene	7157
31703578	2367	2370	P21	Gene	644914
31703578	2371	2380	rs1801270	SNP	tmVar:rs1801270;VariantGroup:0;CorrespondingGene:1026;RS#:1801270;CorrespondingSpecies:9606
31703578	2385	2389	TP53	Gene	7157
31703578	2390	2399	rs1042522	SNP	tmVar:rs1042522;VariantGroup:2;CorrespondingGene:7157;RS#:1042522;CorrespondingSpecies:9606
31703578	2447	2449	PE	Disease	MESH:D011225
31703578	2451	2454	P21	Gene	644914
31703578	2455	2464	rs1801270	SNP	tmVar:rs1801270;VariantGroup:0;CorrespondingGene:1026;RS#:1801270;CorrespondingSpecies:9606
31703578	2495	2498	P21	Gene	644914
31703578	2541	2544	P21	Gene	644914
31703578	2549	2553	TP53	Gene	7157
31703578	2612	2614	PE	Disease	MESH:D011225
31703578	Negative_Correlation	MESH:D011225	RS#:1042522;CorrespondingGene:7157
31703578	Negative_Correlation	MESH:D011225	RS#:1801270;CorrespondingGene:1026
31703578	Negative_Correlation	MESH:D011225	644914
31703578	Association	MESH:D011225	7157
31703578	Association	MESH:D011225	7157
31703578	Association	MESH:D011225	1026

